Moulay A. Alaoui-Jamali
Affiliations: | McGill University, Montreal, QC, Canada |
Area:
Molecular Biology, Oncology, Microbiology BiologyGoogle:
"Moulay Alaoui-Jamali"Children
Sign in to add traineeIris J. Groisman | grad student | 2001 | McGill |
Daniela Marcantonio | grad student | 2001 | McGill |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
de Lima JM, Morand GB, Macedo CCS, et al. (2020) Ndrg1 Deficiency is associated with Regional Metastasis in Oral Cancer by inducing Epithelial-Mesenchymal transition. Carcinogenesis |
Sirois I, Aguilar-Mahecha A, Lafleur J, et al. (2019) A unique morphological phenotype in chemoresistant triple negative breast cancer reveals metabolic reprogramming and PLIN4 expression as a molecular vulnerability. Molecular Cancer Research : McR |
Shorstova T, Marques M, Su J, et al. (2019) SWI/SNF-compromised cancers are susceptible to bromodomain inhibitors. Cancer Research |
Chang CH, Bijian K, Wernic D, et al. (2019) A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy. Autophagy |
Guo Q, Li VZ, Nichol JN, et al. (2019) MNK1/NODAL signaling promotes invasive progression of breast ductal carcinoma in situ. Cancer Research |
Marques M, Jangal M, Wang LC, et al. (2018) Oncogenic activity of poly (ADP-ribose) glycohydrolase. Oncogene |
Daniela da Silva S, Xu B, Maschietto M, et al. (2018) TRAF2 COOPERATES WITH FOCAL ADHESION SIGNALING TO REGULATE CANCER CELL SUSCEPTIBILITY TO ANOIKIS. Molecular Cancer Therapeutics |
Li L, Guturi KKN, Gautreau B, et al. (2018) Ubiquitin ligase RNF8 suppresses Notch signaling to regulate mammary development and tumorigenesis. The Journal of Clinical Investigation |
Carnielli CM, Macedo CCS, De Rossi T, et al. (2018) Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer. Nature Communications. 9: 3598 |
Ghashghaei M, Muanza T, Alaoui-Jamali M, et al. (2018) Abstract 858: Enzalutamide versus abiraterone as a radiosensitizer in hormone-sensitive prostate cancer cells Cancer Research. 78: 858-858 |